The prosecution had some key pieces of evidence.
The government's case against Elizabeth Holmes, the founder of Theranos, featured several key pieces of evidence that showed she deceived doctors, patients and investors in the blood testing start-up.
They were included.
In 2010, Theranos created a report that displayed the logos of pharmaceutical companies. The report helped persuade investors to invest in Theranos, as evidenced by the testimony of investors such as Lisa Peterson, who manages investments for the wealthy DeVos family.
The problem? The report was not signed off by Pfizer, Schering-Plough and Glaxo. Daniel Edlin, a former Theranos senior product manager, testified that Ms. Holmes had signed off on all investor material.
The image is.
The report implied endorsements from pharmaceutical companies.
The Department of Defense and Theranos had discussions about the possible deployment of the company's technology in the battlefield.
The investors testified that Ms.Holmes told them that Theranos had signed contracts with the U.S. military.
They had been doing work for pharma companies and the government for a long time.
In a taped shareholder call, jurors have to hear those claims for themselves.
In the recording, Ms. Holmes said that the business was built around partnerships with pharmaceutical companies and military contracts.
The image is.
The start-up Theranos worked with pharmaceutical companies and the military.
The majority of the prosecution's exhibits were emails between Theranos employees. Some of the emails showed that Theranos fudged its blood testing results and hid device failures.
Mr. Edlin asked a colleague for advice on how to show off the technology to potential investors.
The demo app was recommended by Michael Craig to Mr. Edlin, because it said if an error had taken place, it would be run or processed.
Mr. Craig wrote in an email that the app would hide failures.
Mr. Edlin said it was a good thing. Thanks for demo, let's go with it.
The image is.
The employees of Theranos were going to show the company's technology.
